The future of medicine in 2016

Genomics will provide medical opportunities next year – while diabetes and TB are among the greatest challenges, experts say today.

The journal PLoS Medicine today (30 December) publishes comments from 11 researchers and clinicians, including those working in cardiovascular disease, diabetes and cancer, about expected changes in medicine.

Dr Ewan Birney of the European Molecular Biology Laboratory in Hinxton, Cambridgeshire, UK, works in clinical genomics. He states that genomics has transformed the diagnosis of rare diseases, and enabled new discoveries.

"With other projects, such as ClinGen in America and the 100K Genomes in the UK, this will impact more and more people over the next year," Dr Birney writes. "New technologies are going to bring down the cost, and I think this will have an impact across genomics, first in structural variation but then more broadly," he adds.

Dr Philipp du Cros of Médecins Sans Frontières spoke to the journal about tuberculosis.

He says: "Multidrug-resistant tuberculosis is a public health emergency that threatens progress in tuberculosis care and control. Standard treatment is hugely inadequate: lengthy, toxic, expensive, and has a 50% failure rate."

Dr du Cros calls for an urgent scale-up of two new drugs – bedaquiline and delamanid – as well as clinical trials on the best drug combinations for shorter, more effective regimens.

On the subject of diabetes, Dr Nick Wareham of Cambridge University, UK, says: "Our immediate public health goal should be to limit and ideally reverse the increase in the incidence of the condition."

He believes there is a great public health benefit from "population approaches that seek to promote small changes in behaviour in large groups of people at low to moderate risk". "This strategy makes the greatest impact on the epidemic of diabetes," he concludes.

The PLOS Medicine Editors, Beck, A. et al. Progress in Medicine: Experts Take Stock. PLoS Medicine 30 December 2015 doi:10.1371/journal.pmed.1001933; [abstract]

, , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index